XML 74 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Comprehensive Income (Loss) (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended 12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Statement [Abstract]          
Revenue $ 21,283 $ 16,480 $ 22,973 $ 17,800 $ 11,730
Costs and expenses          
Cost of revenue 10,188 9,076 12,361 9,777 9,128
Research and development 10,469 8,253 11,635 8,990 7,547
Selling, general and administrative 20,822 10,588 15,486 9,529 8,027
Total costs and expenses 41,479 27,917 39,482 28,296 24,702
Loss from operations (20,196) (11,437) (16,509) (10,496) (12,972)
Other income (expense)          
Interest income 28 17 21 10 29
Interest expense (1,412) (551) (804) (599) (94)
Other income (expense) (30) (26) (29) 80 254
Revaluation of preferred stock warrant liability 1,156 150 (387) 73 15
Total other income (expense) (258) (410) (1,199) (436) 204
Net loss (20,454) (11,847) (17,708) (10,932) (12,768)
Accretion of mandatorily redeemable convertible preferred stock (4,653) (5,515) (7,533) (5,251) (4,351)
Net loss attributable to common stockholders (25,107) (17,362) (25,241) (16,183) (17,119)
Net loss per share-basic and diluted $ (4.74) $ (51.06) $ (71.10) $ (50.10) $ (54.17)
Shares used in computing basic and diluted net loss per share 5,292 340 355 323 316
Unrealized gain on short-term investments 5        
Comprehensive loss $ (20,449) $ (11,847) $ (17,708) $ (10,932) $ (12,768)